Cystic Fibrosis

Cystic Fibrosis News

Alert FDA Approves New Drug for a Form of Cystic Fibrosis The FDA has approved ivacaftor for patients aged 6 years and older with cystic fibrosis caused by the G551D mutation in the CFTR gene.
FDA Approvals, January 31, 2012
Pancrelipases, Xerese Cream Returned for Routine Monitoring Three pancrelipase formulations and an acyclovir/hydrocortisone cream have been returned for routine monitoring after US Food and Drug Administration reviews.
Medscape Medical News, January 30, 2012

Effective New Therapy for Cystic Fibrosis A 48-week, placebo-controlled study finds a new and effective treatment for CF, although there are some limitations.
Medscape Pulmonary Medicine, December 7, 2011
Effect of Azithromycin on Lung Function in Patients With Cystic Fibrosis Does azithromycin improve lung function in patients with cystic fibrosis not infected with Pseudomonas aeruginosa? Dr. Andy Shorr explores the recent data in his latest video blog.
Medscape Pulmonary Medicine, June 3, 2010

Aztreonam Lysine for Inhalation
American Journal of Health-System Pharmacy, February 7, 2012
Intrahospital Exercise in Children with Cystic Fibrosis
Medicine and Science in Sports and Exercise®, January 10, 2012
Kids in America: Newborn Screening for Cystic Fibrosis
Laboratory Medicine, September 29, 2011
New and Investigational Treatments in Cystic Fibrosis
Therapeutic Advances in Respiratory Disease, September 1, 2011
Exacerbations and Outcomes in Adult Cystic Fibrosis
Thorax, August 25, 2011